Dew, At this point in the running do you see a higher chance of a Pharming/GTCB merger? Pharming's got the honey and GTCB has the bees. It would allow for a European and an American base. Both are in the same business and understand the issues at hand and both realize the scope of transgenic medications possible. They currently are hardly competitors and a marriage would increase the value of both stocks especially with the promise of a sustainable GTCB that would bring in major milestone payments. For Pharming, the access to GTCB patents would avoid the cross license issue. Pharming has the dough to support GTCB operations until phase II DIC data. Separate locations of operations spreads the risk of PETA problems or G-d forbid infections. I realize these are not new or original ideas as we discussed most of these issues when you were taking a poll to see who thought what about impending partnerships, but now given the current need for cash it seems like a wise idea to merge IP (which should be VERY attractive to Pharming) in return for sustainability and the potential for great returns. Would there be a monopoly issue? As if. I think both stocks would skyrocket on such an announcement. Reverse split be damned!! Regards to all, bp